Scw Capital Management, LP Axogen, Inc. Transaction History
Scw Capital Management, LP
- $44 Million
- Q3 2022
A detailed history of Scw Capital Management, LP transactions in Axogen, Inc. stock. As of the latest transaction made, Scw Capital Management, LP holds 421,482 shares of AXGN stock, worth $3.18 Million. This represents 11.42% of its overall portfolio holdings.
Number of Shares
421,482
Previous 419,682
0.43%
Holding current value
$3.18 Million
Previous $3.44 Million
46.17%
% of portfolio
11.42%
Previous 7.36%
Shares
3 transactions
Others Institutions Holding AXGN
# of Institutions
126Shares Held
34.1MCall Options Held
80.7KPut Options Held
3.3K-
Arrow Mark Colorado Holdings LLC Denver, CO4.73MShares$35.6 Million0.47% of portfolio
-
Black Rock Inc. New York, NY3.23MShares$24.4 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.18MShares$24 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT3.11MShares$23.4 Million2.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.41MShares$18.2 Million0.0% of portfolio
About Axogen, Inc.
- Ticker AXGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 42,283,700
- Market Cap $319M
- Description
- AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...